3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Carcinoma, Hepatocellular
46
Liver Neoplasms
9
Neoplasm Metastasis
4
Leukemia, Myeloid, Acute
4
Pancreatic Neoplasms
3
Melanoma
3
Carcinoma, Renal Cell
3
Sarcoma
2
Recurrence
2
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Breast Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Relapsed Pediatric Solid Tumor
1
Portal Vein Tumor Thrombus
1
Neoplasms, Glandular and Epithelial
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Mesothelioma
1
Lung Neoplasms
1
Liver Diseases
1
Leukemia, Monocytic, Acute
1
Kidney Neoplasms
1
Hemangiosarcoma
1
HCC
1
Gastrointestinal Neoplasms
1
Interventions
pembrolizumab
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gemcitabine
2
Cisplatin
2
niraparib
1
dostarlimab
1
defactinib
1
Vitamin B 12
1
TroVax
1
Thiostrepton
1
Sorafenib
1
Pemetrexed
1
Oxaliplatin
1
Nivolumab
1
Mitomycin
1
MAC321
1
Leucovorin
1
Immunotherapy, Adoptive
1
Imatinib Mesylate
1
IPI-549
1
Folic Acid
1
Dexamethasone
1
Cytoreduction Surgical Procedures
1
Bortezomib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Mesothelioma
×
Sorafenib
×
Clear all
NCT00794859
2009-08-04
SMS
King's College London
Phase 2
Unknown
54 enrolled